Zymeworks Inc (ZYME)
13.66
-0.90
(-6.15%)
USD |
NASDAQ |
Nov 21, 16:00
13.60
-0.06
(-0.40%)
After-Hours: 20:00
Zymeworks Price to Book Value: 2.563 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.731 |
| November 19, 2024 | 2.772 |
| November 18, 2024 | 2.798 |
| November 15, 2024 | 2.888 |
| November 14, 2024 | 3.052 |
| November 13, 2024 | 3.230 |
| November 12, 2024 | 3.266 |
| November 11, 2024 | 3.253 |
| November 08, 2024 | 3.121 |
| November 07, 2024 | 3.148 |
| November 06, 2024 | 2.930 |
| November 05, 2024 | 2.752 |
| November 04, 2024 | 2.770 |
| November 01, 2024 | 2.492 |
| October 31, 2024 | 2.571 |
| October 30, 2024 | 2.603 |
| October 29, 2024 | 2.582 |
| October 28, 2024 | 2.495 |
| October 25, 2024 | 2.437 |
| October 24, 2024 | 2.435 |
| October 23, 2024 | 2.471 |
| October 22, 2024 | 2.476 |
| October 21, 2024 | 2.482 |
| October 18, 2024 | 2.540 |
| October 17, 2024 | 2.539 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.544 |
| October 15, 2024 | 2.624 |
| October 14, 2024 | 2.522 |
| October 11, 2024 | 2.503 |
| October 10, 2024 | 2.435 |
| October 09, 2024 | 2.414 |
| October 08, 2024 | 2.376 |
| October 07, 2024 | 2.368 |
| October 04, 2024 | 2.384 |
| October 03, 2024 | 2.311 |
| October 02, 2024 | 2.349 |
| October 01, 2024 | 2.342 |
| September 30, 2024 | 2.380 |
| September 27, 2024 | 2.173 |
| September 26, 2024 | 2.181 |
| September 25, 2024 | 2.188 |
| September 24, 2024 | 2.187 |
| September 23, 2024 | 2.232 |
| September 20, 2024 | 2.290 |
| September 19, 2024 | 2.283 |
| September 18, 2024 | 2.190 |
| September 17, 2024 | 2.152 |
| September 16, 2024 | 2.188 |
| September 13, 2024 | 2.194 |
| September 12, 2024 | 2.131 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9398
Minimum
Sep 27 2023
9.002
Maximum
Feb 10 2020
2.810
Average
2.204
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
| Theriva Biologics Inc | 0.1446 |
| Oragenics Inc | 2.223 |
Price to Book Value Related Metrics
| PS Ratio | 16.44 |
| Price | 13.66 |
| Earnings Yield | -10.91% |
| Market Cap | 940.52M |